Posts
Correction of the CAS number of the basic substance chitosan hydrochloride
COMMISSION IMPLEMENTING REGULATION (EU) 2021/1446
of 3 September 2021
correcting Implementing Regulations (EU) No 540/2011 and (EU) No 563/2014 as regards the CAS number of the basic substance chitosan hydrochloride
(Text with EEA relevance)
THE…
Extension of the approval periods of the active substances 2-phenylphenol, 8-hydroxyquinoline, amidosulfuron, bifenox, chlormequat, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, dimethachlor, etofenprox, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sulphur, tetraconazole, tri-allate, triflusulfuron and tritosulfuron
COMMISSION IMPLEMENTING REGULATION (EU) 2021/1449
of 3 September 2021
amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2-phenylphenol (including its salts such as the…
Non-renewal of approval of the active substance famoxadone
COMMISSION IMPLEMENTING REGULATION (EU) 2021/1379
of 19 August 2021
concerning the non-renewal of approval of the active substance famoxadone, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning…
Amendment of the approval periods of the active substances Adoxophyes orana granulovirus and flutriafol
COMMISSION IMPLEMENTING REGULATION (EU) 2021/726
of 4 May 2021
amending Implementing Regulation (EU) No 540/2011 as regards the approval periods of the active substances Adoxophyes orana granulovirus and flutriafol
(Text with EEA relevance)
THE…
Change of conditions of approval of the active substance terbuthylazine (restriction of use)
COMMISSION IMPLEMENTING REGULATION (EU) 2021/824
of 21 May 2021
amending Implementing Regulations (EU) No 540/2011 and (EU) No 820/2011 as regards the conditions of approval of the active substance terbuthylazine
(Text with EEA relevance)
THE…
Extension of the approval periods of the active substances
COMMISSION IMPLEMENTING REGULATION (EU) 2021/745
of 6 May 2021
amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances aluminium ammonium sulphate, aluminium silicate, beflubutamid,…
Renewal of approval of the active substance Streptomyces strain K61
COMMISSION IMPLEMENTING REGULATION (EU) 2021/853
of 27 May 2021
renewing the approval of the active substance Streptomyces strain K61 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning…
Non-approval of fermented extract from leaves of Symphytum officinale L. (comfrey) as a basic substance
COMMISSION IMPLEMENTING REGULATION (EU) 2021/809
of 20 May 2021
concerning the non-approval of fermented extract from leaves of Symphytum officinale L. (comfrey) as a basic substance in accordance with Regulation (EC) No 1107/2009 of the European…
HQ EUROPE
Avenida Diagonal 468, 6th Floor
Barcelona | 08006, Barcelona, Spain
HQ USA
1395 Brickell Avenue, Suite 800 & 900
Miami | FL 33131 USA
HQ LATAM
Calle 24 #95 - A No. 80 - Of. 517
Edificio Colfecar | Bogotá, Colombia
HQ ASIA
Of. 406, Block B, 4/F Mirror Tower, 61 Mody Road
Tsim Sha Tsui East | Hong Kong